Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2021 08:30 ET | Source: Revolo Biotherapeutics

Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases

-- Plans to initiate four Phase 2 trials in second half of 2021-- -- Exploring additional autoimmune and allergic disease indications for portfolio candidates -- NEW ORLEANS and LONDON, March ...
January 08, 2021 08:00 ET | Source: Immune Regulation

Immune Regulation to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference

LONDON AND NEW ORLEANS, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Immune Regulation, LTD, announced today that the company will give a corporate overview at the virtual 39th Annual J.P. Morgan Healthcare...